Demirer, T. Et Al. 2004. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation. Bone Marrow Transplantation , vol.34, no.9 , 781-786.

Demirer, T., Ayli, M., Fen, T., Ozcan, M., Arat, M., Buyukberber, S., ... Arslan, O.(2004). High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation. Bone Marrow Transplantation , vol.34, no.9, 781-786.

Demirer, TANER Et Al. "High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation," Bone Marrow Transplantation , vol.34, no.9, 781-786, 2004

Demirer, TANER Et Al. "High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation." Bone Marrow Transplantation , vol.34, no.9, pp.781-786, 2004

Demirer, T. Et Al. (2004) . "High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation." Bone Marrow Transplantation , vol.34, no.9, pp.781-786.

@article{article, author={TANER DEMİRER Et Al. }, title={High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation}, journal={Bone Marrow Transplantation}, year=2004, pages={781-786} }